Garnett Timothy John

Director Garnett Timothy John buys 14,124 shares of MPLT at $17.89 (Feb 10, 2026)

Garnett Timothy John, a director of MapLight Therapeutics, purchased 14,124 shares at $17.89 on 2026-02-10, establishing an initial stake of 14,124 shares worth $252,678.36. The stock is currently trading at $17.22, down 18.3% from its 52-week high of $21.08 but up 22.2% over the past 90 days, suggesting recent upward momentum. The company is unprofitable with a net loss of $29,418,000.00 and a market cap of $781,323,628.26, typical for early-stage therapeutics. This represents a new director position investment in a loss-making biotech firm, which warrants observation of whether follow-on purchases or insider activity emerges.